GeneBioTech Co. ,Ltd (KOSDAQ:086060)

South Korea flag South Korea · Delayed Price · Currency is KRW
4,620.00
+70.00 (1.54%)
At close: Jul 10, 2026
Market Cap39.78B +7.3%
Revenue (ttm)89.44B +4.4%
Net Income3.59B +22.5%
EPS416.61 +22.2%
Shares Out 8.61M
PE Ratio11.09
Forward PEn/a
Dividend50.00 (1.08%)
Ex-Dividend Daten/a
Volume32,555
Open4,525.00
Previous Close4,550.00
Day's Range4,465.00 - 4,680.00
52-Week Range3,525.00 - 5,990.00
Beta0.31
Analystsn/a
Price Targetn/a
Earnings DateMay 29, 2026

About GeneBioTech Co. ,Ltd

GeneBioTech Co. ,Ltd, together with its subsidiaries, engages in the manufacture and sale of feed additives and functional food in South Korea. It also manufactures and sells animal drugs. The company was founded in 2000 and is headquartered in Gongju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 2000
Employees 42
Stock Exchange KOSDAQ
Ticker Symbol 086060
Full Company Profile

Financial Performance

In 2025, GeneBioTech Co. ,Ltd's revenue was 90.79 billion, an increase of 9.44% compared to the previous year's 82.96 billion. Earnings were 3.79 billion, an increase of 32.23%.

Financial Statements